Oscar Health Inc
For the period ended Mar 31, 2024. Filed May 7, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 7, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Summary of Cash Flows
Net cash provided by operating activities increased $219.6 million to $634.4 million for the three months ended March 31, 2024, compared to $414.7 million for the three months ended March 31, 2023. The increase was primarily due to higher premiums received, which were partially offset by higher claim disbursements. Net cash used in investing activities was $300.6 million for the three months ended March 31, 2024, as compared to $135.5 million of net cash provided by investing activities for the three months ended March 31, 2023. The change was primarily due to an increase in purchased securities and reductions in sales of securities and maturity of investments. Net cash provided by financing activities increased $26.8 million to $27.3 million for the three months ended March 31, 2024, compared to $0.5 million for the three months ended March 31, 2023. The increase was primarily due to proceeds received from exercise of stock options.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.